We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

40 hedge funds and large institutions have $27.1M invested in Cumberland Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more capital invested

Capital invested by funds: $23.6M → $27.1M (+$3.51M)

4% less call options, than puts

Call options by funds: $115K | Put options by funds: $120K

9% less funds holding

Funds holding: 44 → 40 (-4)

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
40
Holders Change
-4
Holders Change %
-9.09%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
11
Reduced
13
Closed
5
Calls
$115K
Puts
$120K
Net Calls
-$5K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$917K
2
AI
Ariel Investments
Illinois
+$269K
3
Renaissance Technologies
Renaissance Technologies
New York
+$55.5K
4
Invesco
Invesco
Georgia
+$9.41K
5
WIC
Woodmont Investment Counsel
Tennessee
+$9.41K

Top Sellers

Rank Fund Capital Flow
1
EGA
Eagle Global Advisors
Texas
-$145K
2
SIM
Spark Investment Management
New York
-$65.4K
3
Citadel Advisors
Citadel Advisors
Florida
-$58K
4
BIT
BlackRock Institutional Trust
California
-$54.8K
5
UCFA
United Capital Financial Advisors
Texas
-$44.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$23K – – –
NFA
27
Nationwide Fund Advisors
Ohio
$19K – – –
OC
28
Oakworth Capital
Alabama
$15K – – –
BIM
29
BlackRock Investment Management
Delaware
$10K – – –
UBS Group
30
UBS Group
Switzerland
$10K +$5.01K +1,065 +119%
WIC
31
Woodmont Investment Counsel
Tennessee
$10K +$9.41K +2,000 New
Deutsche Bank
32
Deutsche Bank
Germany
$7K +$2.6K +553 +49%
TRCT
33
Tower Research Capital (TRC)
New York
$7K +$5.71K +1,214 +1,214%
MFS
34
MSI Financial Services
Massachusetts
$5K – – –
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K – – –
Walleye Trading
36
Walleye Trading
New York
$2K -$2.05K -436 -48%
MA
37
MUFG Americas
New York
$2K -$1.13K -240 -34%
SEI Investments
38
SEI Investments
Pennsylvania
$2K +$329 +70 +28%
TDC
39
Thompson Davis & Co
Virginia
$1K – – –
Citadel Advisors
40
Citadel Advisors
Florida
– -$58K -12,895 Closed
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
– -$9K -2,000 Closed
Citigroup
42
Citigroup
New York
– -$5K -1,200 Closed
UMA
43
USA Mutuals Advisors
Texas
– -$3K -738 Closed
1
2

CPIX Hedge Fund Activity: Q3 2016 in Review

40 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2016, worth a combined $27.1M — up 15% from $23.6M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CPIX and 1 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 11 added.

The largest buyer was Stonepine Capital Management, adding an estimated $917K. The largest seller was Eagle Global Advisors, cutting an estimated $145K.

  • 40 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2016, down from 44 in Q2 2016.
  • Funds reported $27.1M of Cumberland Pharmaceuticals stock for Q3 2016, up 15% quarter-over-quarter.
  • 1 fund opened new Cumberland Pharmaceuticals positions in Q3 2016 and 5 closed out, a net change of -4 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q3 2016 was Stonepine Capital Management, an estimated $917K added.
  • The largest Cumberland Pharmaceuticals seller in Q3 2016 was Eagle Global Advisors, an estimated $145K sold.

Based on aggregated 13F filings for Q3 2016.